Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥12.4bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥22.5bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥11.4bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥1.6bn2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥1.9bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥1.7bn2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥3.5bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.9bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥1.7bn2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥2.1bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥1.1bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.2bn2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥1.5bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥34.9bnat 2025-09-30Cons.Assets
Total assets¥35.4bnat 2025-03-31Cons.Assets
Total assets¥32.6bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥10.2bnat 2025-09-30Cons.Liabilities
Total liabilities¥9.8bnat 2025-03-31Cons.Liabilities
Net assets / equity¥24.7bnat 2025-09-30Cons.Net assets
Net assets / equity¥25.5bnat 2025-03-31Cons.Net assets
Net assets / equity¥24.4bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥13.7bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥15.4bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥13.7bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥15.4bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥15.7bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥14.0bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow¥1.4bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.7bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥998m2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥1.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.9bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥553m2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥703m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥145.462025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥292.412024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥170.42024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio66.4%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio67.8%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio70.3%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Medical Relatedreportable segmentrevenue2025-04-01 → 2025-09-30¥1.5bn
Medical Relatedreportable segmentrevenue external2025-04-01 → 2025-09-30¥1.5bn
Medical Relatedreportable segmentsegment profit2025-04-01 → 2025-09-30¥108m
Water Health Carereportable segmentrevenue2025-04-01 → 2025-09-30¥10.9bn
Water Health Carereportable segmentrevenue external2025-04-01 → 2025-09-30¥10.9bn
Water Health Carereportable segmentsegment profit2025-04-01 → 2025-09-30¥1.5bn
—segment totalrevenue2025-04-01 → 2025-09-30¥12.4bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥12.4bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥1.6bn
Medical Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥1.4bn
Medical Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.4bn
Medical Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30¥215m
Water Health Carereportable segmentrevenue2024-04-01 → 2024-09-30¥9.9bn
Water Health Carereportable segmentrevenue external2024-04-01 → 2024-09-30¥9.9bn
Water Health Carereportable segmentsegment profit2024-04-01 → 2024-09-30¥1.6bn
—segment totalrevenue2024-04-01 → 2024-09-30¥11.4bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥11.4bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥1.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 518
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)有限責任 あずさ監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)西  野  裕  久
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)杉  田  直  樹  
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1InterimDuration11361310000JPY
Net sales (5-year summary)InterimDuration12406169000JPY
Net sales (5-year summary)Prior1YearDuration22463830000JPY
Ordinary income loss (5-year summary)Prior1InterimDuration1949901000JPY
Ordinary income loss (5-year summary)InterimDuration1676091000JPY
Ordinary income loss (5-year summary)Prior1YearDuration3535276000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1InterimDuration1306125000JPY
Profit loss attributable to owners of parent (5-year summary)InterimDuration1106981000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration2241402000JPY
Comprehensive income (5-year summary)Prior1InterimDuration1470630000JPY
Comprehensive income (5-year summary)InterimDuration1016361000JPY
Comprehensive income (5-year summary)Prior1YearDuration2584501000JPY
Net assets (5-year summary)Prior1InterimInstant24409304000JPY
Net assets (5-year summary)InterimInstant24720706000JPY
Net assets (5-year summary)Prior1YearInstant25546169000JPY
Total assets (5-year summary)Prior1InterimInstant32633462000JPY
Total assets (5-year summary)InterimInstant34926229000JPY
Total assets (5-year summary)Prior1YearInstant35353779000JPY
Basic earnings loss per share (5-year summary)Prior1InterimDuration170.40
Basic earnings loss per share (5-year summary)InterimDuration145.46
Basic earnings loss per share (5-year summary)Prior1YearDuration292.41
Diluted earnings per share (5-year summary)Prior1InterimDuration-
Diluted earnings per share (5-year summary)InterimDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1InterimInstant0.703
Equity to asset ratio (5-year summary)InterimInstant0.664
Equity to asset ratio (5-year summary)Prior1YearInstant0.678
Net cash provided by used in operating activities (5-year summary)Prior1InterimDuration1175508000JPY
Net cash provided by used in operating activities (5-year summary)InterimDuration1410706000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration2675358000JPY
Net cash provided by used in investing activities (5-year summary)Prior1InterimDuration1123893000JPY
Net cash provided by used in investing activities (5-year summary)InterimDuration-997915000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration-1887396000JPY
Net cash provided by used in financing activities (5-year summary)Prior1InterimDuration-702630000JPY
Net cash provided by used in financing activities (5-year summary)InterimDuration-1903298000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration552580000JPY
Cash and cash equivalents (5-year summary)Prior1InterimInstant15658644000JPY
Cash and cash equivalents (5-year summary)InterimInstant13748586000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant15394490000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember8656780
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember8656780
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant8656780
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant8656780
Number of shares heldInterimInstant_No1MajorShareholdersMember3350580
Shareholding ratioInterimInstant_No1MajorShareholdersMember0.4121

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass